Prosecution Insights
Last updated: July 05, 2026
Application No. 18/632,849

BODY SHAPE COMPLIANT WEARABLE PHYSIOLOGICAL MONITOR AND SYSTEM

Non-Final OA §101§112
Filed
Apr 11, 2024
Priority
Apr 13, 2023 — provisional 63/495,781
Examiner
HULBERT, AMANDA K
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Atlasense Biomed Ltd.
OA Round
1 (Non-Final)
84%
Grant Probability
Favorable
1-2
OA Rounds
11m
Est. Remaining
88%
With Interview

Examiner Intelligence

Grants 84% — above average
84%
Career Allowance Rate
639 granted / 757 resolved
+14.4% vs TC avg
Minimal +4% lift
Without
With
+3.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
34 currently pending
Career history
795
Total Applications
across all art units

Statute-Specific Performance

§101
1.6%
-38.4% vs TC avg
§103
68.0%
+28.0% vs TC avg
§102
12.9%
-27.1% vs TC avg
§112
10.8%
-29.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 757 resolved cases

Office Action

§101 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Claims 14-21 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected Groups II and III, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on March 30, 2026. Currently claims 1-21 are pending in this application, with claims 14-21 withdrawn from consideration. Claim Rejections - 35 USC § 101 Section 33(a) of the America Invents Act reads as follows: Notwithstanding any other provision of law, no patent may issue on a claim directed to or encompassing a human organism. Claims 1-13 are rejected under 35 U.S.C. 101 and section 33(a) of the America Invents Act as being directed to or encompassing a human organism. See also Animals - Patentability, 1077 Off. Gaz. Pat. Office 24 (April 21, 1987) (indicating that human organisms are excluded from the scope of patentable subject matter under 35 U.S.C. 101). Claim 1, line 3 includes the phrase “direct skin contacting sensor.” This appears to be claiming a connection to the human body. Claim 1, line 7-8 recite the phrase “wherein the DSC sensor is part of a bottom of the central housing, the DSC sensor is in direct contact with the subject's body.” This is positively reciting the subject’s body. It is suggested to claim the device “configured for direct contact” or other similar language. Similar issues exist in claim 5, “wherein the plurality of legs is connected to the central housing such that the plurality of legs hold the central housing in contact with the subject's body.” Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-13 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1, lines 9-13 recites the phrase “wherein each of two or more legs of the plurality of legs attaches to the subject's body, and to a flexible elbow between one of the two or more legs and the central housing; wherein the flexible elbow allows movement of each of the two or more legs in respect to the central housing in three or more degrees of freedom.” This phrase is unclear, as it is not clear if the claim is attempting to recite (at minimum): two legs each attached to respective elbows (2 legs, 2 elbow); or two legs attached to a single elbow (2 legs 1, elbow). There is no support in the specification has originally filed for one elbow to be attached to two separate legs. It is suggested to more clearly define that each leg is attached to a separate elbow. Allowable Subject Matter Claims 1-14 would be allowable if rewritten or amended to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, and those under 35 U.S.C. 101 as set forth in this Office action. The following is a statement of reasons for the indication of allowable subject matter: The prior art of record does not disclose wearable physiological monitor with flexible elbows and legs in the same configuration as required by the claims. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Vosch (US 2015/0022372) discloses an ECG recorder. Felix (US 2015/0082623) disclose a wearable physiological electrode assembly. Hayes-Gill (US 2016/0262649) discloses an abdominal electrophysiological sensor. Li (US 2016/0317057) discloses an attachable sensor with flexible legs. Spencer (US 2017/0095177) discloses an electrode patch. Galgalikar (USPN 11,058,314) discloses an electrode recording system. Abercrombie (US 2022/0039720) disclose a wearable device with a flexible bridge portion. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Amanda K Hulbert whose telephone number is (571)270-1912. The examiner can normally be reached Monday - Friday 9:00-5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Unsu Jung can be reached at 571-272-8506. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Amanda K Hulbert/ Primary Examiner, Art Unit 3792
Read full office action

Prosecution Timeline

Apr 11, 2024
Application Filed
May 13, 2026
Non-Final Rejection mailed — §101, §112
Jun 22, 2026
Examiner Interview Summary
Jun 22, 2026
Applicant Interview (Telephonic)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12665061
NOCICEPTION EVENT IDENTIFICATION BASED ON A RELATIVE CHANGE IN A NOCICEPTION PARAMETER
3y 2m to grant Granted Jun 23, 2026
Patent 12654013
MEMORY ENHANCEMENT BY PREFRONTAL DEEP BRAIN STIMULATION SYNCHRONIZED TO MEDIAL TEMPORAL LOBE DURING SLEEP
2y 6m to grant Granted Jun 16, 2026
Patent 12642972
PERIPHERAL NERVE AND SPINAL CORD DIFFERENTIAL TARGET MULTIPLEXED STIMULATION
2y 9m to grant Granted Jun 02, 2026
Patent 12642977
Implantable Medical Device Comprising an Electrical Line Forming an Antenna
2y 7m to grant Granted Jun 02, 2026
Patent 12642988
DEVICE FOR RELIEVING DEMENTIA SYMPTOMS
1y 9m to grant Granted Jun 02, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
84%
Grant Probability
88%
With Interview (+3.9%)
3y 2m (~11m remaining)
Median Time to Grant
Low
PTA Risk
Based on 757 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month